Access cutting-edge chronic lymphocytic leukemia treatment through this clinical trial at a research site in Whittier. Study-provided care at no cost to qualified participants.
Access chronic lymphocytic leukemia specialists in Whittier at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic lymphocytic leukemia treatment provided free
The purpose of this study is to evaluate the efficacy and safety of ibrutinib + venetoclax (I+V) and ibrutinib monotherapy regimens in which dosing of ibrutinib is either proactively reduced or reactively modified in response to adverse events (AEs).
Sponsor: Janssen Research & Development, LLC
Check if you qualify for this chronic lymphocytic leukemia clinical trial in Whittier, CA
If you're searching for chronic lymphocytic leukemia treatment options in Whittier, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Whittier research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic lymphocytic leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.